BLTE
Belite Bio Inc
169.80$
+1.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +76.5% | +560.0% | +101.5% | +12.5% | +3.3% | |
| – | +12.3% | -3.1% | +157.8% | +135.1% | +333.1% | |
| – | +11.7% | – | – | – | – | |
| – | – | -176.7% | – | – | +125.3% | |
| – | +270.0% | +432.4% | -84.0% | +139.7% | +17.9% | |
| – | +180.0% | +603.6% | -84.0% | +175,411.1% | +175.9% | |
| – | -100.0% | – | – | – | – | |
| – | -102.1% | – | +105.5% | +10.1% | +693.4% | |
| – | -135.1% | – | +86.2% | -222.6% | – | |
| – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.